Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00399191 · ClinicalTrials.gov registry record · Phase 1
A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia
A Phase 1 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT00399191 is a Phase 1 study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 15 participants.
The verdict
NCT00399191, a Phase 1 study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The objective of the study is to develop a simple, noninvasive test for evaluation of iron absorption as a tool to determine the cause of iron deficiency anemia. Healthy, premenopausal women with iron deficiency with or without anemia will be recruited for the study. Participants will, over the course of two months, ingest an iron solution three times; after each iron ingestion, participants will collect their stool and bring it to the study investigators for assessment of iron content.
Interventions
- DRUG stable isotope of iron, dysprosium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2006-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00399191
The ClinicalTrials.gov registry entry for NCT00399191 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which stable isotope of iron, dysprosium is the first listed.
NCT00399191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00399191 about?
NCT00399191 is a clinical study titled "A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia". The objective of the study is to develop a simple, noninvasive test for evaluation of iron absorption as a tool to determine the cause of iron deficiency anemia. Healthy, premenopausal women with iron deficiency with or without anemia will be recruited for the study. Participants will, over the cour...
What is the current status of trial NCT00399191?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2006-08.
What interventions are being tested in trial NCT00399191?
The interventions under investigation include: stable isotope of iron, dysprosium (DRUG).
Who is sponsoring clinical trial NCT00399191?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.